Lifshitz & Miller LLP Announces Investigation of Bingo Nation Inc., BofI Holding, Inc., Corbus Pharmaceuticals Holdings, Inc., Lion Biotechnologies, Inc., NewLink Genetics Corporation, Power Solutions International, Inc., Walter Investment Management Corp. and XBIOTECH INC.

NEW YORK, May 3, 2017 /PRNewswire/ -- Bingo Nation Inc. (BLTO)

Lifshitz & Miller announces investigation on behalf of BLTO investors concerning whether BLTO engaged in an illegal scheme to promote its securities.

If you are a BLTO investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

BofI Holding, Inc. (BOFI)

Lifshitz & Miller announces investigation on behalf of BOFI investors concerning whether BOFI engaged in money laundering and is subject of a criminal probe by the Justice Department, SEC and Treasury Department.

If you are a BOFI investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Lifshitz & Miller announces investigation on behalf of CRBP investors concerning its data from the Phase 2 study of anabasum to treat cystic fibrosis.

If you are a CRBP investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Lion Biotechnologies, Inc. (LBIO)

Lifshitz & Miller announces investigation on behalf of LBIO investors concerning whether LBIO's former CEO engaged in a scheme to pay for misleading promotional articles touting LBIO's stock.

If you are an LBIO investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

NewLink Genetics Corporation (NLNK)

Lifshitz & Miller announces investigation on behalf of NLNK investors concerning whether NLNK issued misleading statements about its Phase 2 trial data for indoximod.

If you are an NLNK investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Power Solutions International, Inc. (PSIX)

Lifshitz & Miller announces investigation on behalf of PSIX investors after PSIX revealed it would restate its financial statements for the fiscal year 2014 and first quarter 2015.

If you are a PSIX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Walter Investment Management Corp. (WAC)

Lifshitz & Miller announces investigation on behalf of WAC investors concerning whether WAC and its subsidiary, Ditech, lacked effective internal controls over financial reporting.

If you are a WAC investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

XBIOTECH INC. (XBIT)

Lifshitz & Miller announces investigation on behalf of XBIT investors concerning whether XBIT issued misleading statements about its candidate antibody for the treatment of colorectal cancer.

If you are an XBIT investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

ATTORNEY ADVERTISING. © 2017 Lifshitz & Miller LLP.  The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone:  516-493-9780 
Facsimile: 516-280-7376
Email: [email protected]

SOURCE Lifshitz & Miller Law Firm

Related Links

http://jlclasslaw.com